Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery
Public ClinicalTrials.gov record NCT04711837. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery.
Study identification
- NCT ID
- NCT04711837
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Haisco-USA Pharmaceuticals, Inc.
- Industry
- Enrollment
- 255 participants
Conditions and interventions
Conditions
Interventions
- HSK3486 Drug
- Propofol Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 10, 2021
- Primary completion
- Apr 12, 2022
- Completion
- Apr 19, 2022
- Last update posted
- Oct 9, 2025
2021 – 2022
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85053 | — |
| Lotus Clinical Research, LLC | Pasadena | California | 91105 | — |
| Phoenix Clinical Research, LLC | Tamarac | Florida | 33321 | — |
| The University of Chicago Medicine | Chicago | Illinois | 60637 | — |
| New York City Heath and Hospitals | New York | New York | 10013 | — |
| Stony Brook University Hospital | Stony Brook | New York | 11794 | — |
| UNC Health Care System | Chapel Hill | North Carolina | 27599 | — |
| Duke University | Durham | North Carolina | 27705 | — |
| The Ohio State University Research Foundation | Columbus | Ohio | 43210 | — |
| HD Research | Bellaire | Texas | 77401 | — |
| Plano Surgical Hospital | Plano | Texas | 75093 | — |
| Endeavor Clinical Trials, LLC | San Antonio | Texas | 78229 | — |
| JBR Clinical Research | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04711837, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04711837 live on ClinicalTrials.gov.